Study of Tapering and Discontinuing Biological DMARDs in Rheumatoid Arthritis Patients

• Conditions: Rheumatoid Arthritis

• Registration Number: NCT04472390
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

This study aims to analyses time to disease relapse of RA patients if TNF-α inhibitors are being tapered, the predictive factors that are associated with successful taper of TNF-α inhibitors. Also, investigate the effects associated with dose tapering of TNF-α inhibitors.

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-12
• Study Start: 2019-12-03
• Study First Submitted: 2020-07-08
• Study First Submitted QC: 2020-07-13
• Last Update Submitted: 2020-07-13
• Study First Posted: 2020-07-15
• Last Update Posted: 2020-07-15
• Primary Completion: 2021-12
• Study Completion: 2021-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
time to disease relapse	hrough study completion, an average of 10 year	me to relapse after tapering or discontinuing TNF-α inhibitors

Trial Locations

Locations (1)

National Taiwan University Hospital; 🇨🇳 Taipei, Zhongzheng District, Taiwan